![Christopher Mason](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Christopher Mason was the founder of Stem Cell Translation Ltd. (2006) serving as Director until 2018, London Regenerative Medicine Network Ltd. (2008) serving as Director since 2008, Oribiotech Ltd. (2015) serving as Non-Executive Director, AVROBIO, Inc. (2015) serving as Chief Scientific Officer from 2015 to 2022, and Sun Vectors, Inc. (2022) serving as Chief Executive Officer & Director since 2022.
Current jobs include Director at Alliance for Regenerative Medicine since 2021, Independent Director at Krystal Biotech, Inc. since 2021, and Professor at University College London since 1999.
Former jobs include Trustee at UK Stem Cell Foundation from 2010 to 2016 and Trustee at The British Neurological Research Trust from 2012 to 2016.
Education includes undergraduate degree from Imperial College London, doctorate degrees from University College London and King's College London.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 23/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Direttore/Membro del Consiglio | 04/01/2021 |
London Regenerative Medicine Network Ltd. | Fondatore | 01/02/2008 |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Direttore/Membro del Consiglio | 01/10/2021 |
| Società | Posizione | Fine |
|---|---|---|
| TECTONIC THERAPEUTIC, INC. | Fondatore | 30/06/2022 |
Stem Cell Translation Ltd. | Fondatore | 01/03/2018 |
The British Neurological Research Trust | Direttore/Membro del Consiglio | 01/05/2016 |
UK Stem Cell Foundation
 UK Stem Cell Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direttore/Membro del Consiglio | 01/05/2016 |
Oribiotech Ltd.
 Oribiotech Ltd. BiotechnologyHealth Technology Develops and manufactures cell and gene therapy | Fondatore | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UK Stem Cell Foundation
UK Stem Cell Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
The British Neurological Research Trust | |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
Krystal Biotech, Inc.
 Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Oribiotech Ltd.
Oribiotech Ltd. BiotechnologyHealth Technology Develops and manufactures cell and gene therapy | Health Technology |
London Regenerative Medicine Network Ltd. | |
Stem Cell Translation Ltd. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
